Pub. L. 115-52, tit. III, sec. 304 (as amended)

REAUTHORIZATION; REPORTING REQUIREMENTS.

Year: 2022Length: 76 wordsOfficial source
SEC. 304. REAUTHORIZATION; REPORTING REQUIREMENTS. Section 744C of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-43) is amended— (1) in subsection (a)— (A) by striking “2013” and inserting “2018”; and (B) by striking “Generic Drug User Fee Amendments of 2012” and inserting “Generic Drug User Fee Amendments of 2017”; (2) in subsection (b), by striking “2013” and inserting “2018”; and (3) in subsection (d), by striking “2017” each place it appears and inserting “2022”.
Pub. L. 115-52, tit. III, sec. 304 (as amended): REAUTHORIZATION; REPORTING REQUIREMENTS. | Justis AI